Stock-Based Compensation (Tables)
|
12 Months Ended |
Dec. 31, 2019 |
Share-based Payment Arrangement [Abstract] |
|
Schedule of Share-based Payment Award, Valuation Assumptions |
The fair value of each stock option granted is estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted average assumptions: | | | | | | | | | | | | | | | | | | | Year Ended December 31, | | | | | | 2019 | | 2018 | | 2017 | Risk-free interest rate | 2.5 | % | | 2.8 | % | | 2.1 | % | Average expected life in years | 6.50 | | 6.50 | | 6.50 | Expected volatility | 41.0 | % | | 40.4 | % | | 39.6 | % | Expected dividend yield | — | % | | — | % | | — | % |
|
Summary Of Stock Options Activity |
A summary of the Company’s stock options as of December 31, 2019, 2018 and 2017, and changes during the years then ended is presented below: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | (In thousands, except per share amounts) | | Year Ended December 31, | | | | | | | | | | | | | 2019 | | | | 2018 | | | | 2017 | | | | | Number of Stock Options | | Weighted Average Exercise Price | | Number of Stock Options | | Weighted Average Exercise Price | | Number of Stock Options | | Weighted Average Exercise Price | Outstanding, beginning of year | | 2,732 | | | $ | 12.98 | | | 3,782 | | | $ | 12.71 | | | 4,265 | | | $ | 9.63 | | Granted, at fair market value | | 460 | | | 19.39 | | | 579 | | | 15.41 | | | 734 | | | 19.04 | | Exercised | | (733) | | | 3.41 | | | (1,262) | | | 5.53 | | | (1,046) | | | 3.72 | | Expired | | — | | | — | | | — | | | — | | | — | | | — | | Forfeited | | (490) | | | 19.04 | | | (367) | | | 35.55 | | | (171) | | | 17.59 | | Outstanding, end of year | | 1,969 | | | $ | 16.61 | | | 2,732 | | | $ | 12.98 | | | 3,782 | | | $ | 12.71 | | Options exercisable, end of year | | 913 | | | $ | 15.45 | | | 1,366 | | | $ | 7.70 | | | 2,512 | | | $ | 5.85 | |
|
Stock Options Outstanding And Exercisable |
The following table summarizes information about stock options outstanding and exercisable as of December 31, 2019: (In thousands, except per share amounts) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Options Outstanding | | | | | | | | Options Exercisable | | | | | | | Number of Underlying Shares | | Weighted Average Exercise Price Per Share | | Weighted Average Remaining Contractual Life (Years) | | Total Intrinsic Value | | Number of Underlying Shares | | Weighted Average Exercise Price Per Share | | Weighted Average Remaining Contractual Life (Years) | | Total Intrinsic Value | 1,969 | | | $ | 16.61 | | | 6.19 | | $ | 9,379 | | | 913 | | | $ | 15.45 | | | 3.66 | | $ | 7,725 | |
|
Summary Of Restricted Stock And Restricted Stock Units |
A summary of the Company’s restricted stock and restricted stock units as of December 31, 2019, 2018 and 2017, and changes during the years then ended is presented below: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Year Ended December 31, | | | | | | | | | | | | | 2019 | | | | 2018 | | | | 2017 | | | (In thousands, except per share amounts) | | Number of Restricted Shares | | Weighted Average Grant Date Fair Value | | Number of Restricted Shares | | Weighted Average Fair Value | | Number of Restricted Shares | | Weighted Average Fair Value | Outstanding, beginning of year | | 8,284 | | | $ | 18.03 | | | 9,923 | | | $ | 24.41 | | | 6,771 | | | $ | 19.68 | | Granted | | 3,501 | | | 19.32 | | | 5,165 | | | 15.57 | | | 7,630 | | | 18.84 | | Forfeited | | (2,760) | | | 18.56 | | | (4,745) | | | 27.43 | | | (2,290) | | | 28.71 | | Vested | | (2,364) | | | 20.24 | | | (2,059) | | | 24.95 | | | (2,188) | | | 24.78 | | Outstanding, end of year | | 6,661 | | | $ | 18.02 | | | 8,284 | | | $ | 18.03 | | | 9,923 | | | $ | 24.41 | |
|